RESOMER® LT 706 S is a polymer of a L-lactide-co-trimethylene carbonate with an inherent viscosity range of 1.2 – 1.6 dL/g
It is supplied in white to off-white granules or chips and may be used for bioresorbable, implantable medical devices.
Typical Applications
Typical applications of RESOMER® LT family:
- Blended with other RESOMER® polymers for enhanced ductility
- Foils, Membranes, balloons
Benefits at a glance
RESOMER® is a leading solution in the field of biocompatible polymers, offering a range of essential characteristics that cater to the needs of companies developing implantable devices. Here are some key highlights of RESOMER®:
These features make RESOMER® an ideal choice for companies looking to enhance the biocompatibility and functionality of their implantable devices.
- Bioresorbability: All RESOMER® polymers are 100% bioresorbable, meaning they can be completely metabolized by the body without leaving harmful residues.
- Established Safety: With over 30 years of commercial use, RESOMER® polymers have a proven safety profile across various application areas.
- Versatile Degradation Profiles: The polymers offer a wide range of degradation profiles, allowing for customization based on specific application needs, from less than one month to over four years.
- Mechanical Properties: They provide highly versatile mechanical properties that can be tailored to meet specific requirements, ensuring optimal performance in different applications.
- Processing Flexibility: RESOMER® polymers can be easily processed using standard methods such as extrusion, injection molding, medical textile manufacturing, 3D printing, and electrospinning.
- Sterilization Compatibility: They are compatible with common sterilization techniques, making them suitable for medical applications.
- Shelf Life: RESOMER® polymers have an average shelf life of five years, ensuring reliability and stability for manufacturers.
These features make RESOMER® an ideal choice for companies looking to enhance the biocompatibility and functionality of their implantable devices.
